ARIAD to Host Conference Call and Webcast Discussion of First Quarter 2013
Financial Results on May 7, 2013
CAMBRIDGE, Mass. -- April 23, 2013
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will report
its first quarter 2013 financial results on Tuesday, May 7, 2013, before the
market opens. Following the announcement, at 8:30 a.m. Eastern Time, company
management will host a conference call and webcast discussion of the results
and provide a general corporate update.
The live webcast can be accessed by visiting the investor relations section of
the Company’s website at http://investor.ariad.com. The call can be accessed
by dialing 866- 515-2914 (domestic) or 617-399-5128 (international) five
minutes prior to the start time and providing the pass code 43738421. A replay
of the call will be available on the ARIAD website approximately two hours
after completion of the call and will be archived for three weeks.
ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts and
Lausanne, Switzerland, is an integrated global oncology company focused on
transforming the lives of cancer patients with breakthrough medicines. ARIAD
is working on new medicines to advance the treatment of various forms of
chronic and acute leukemia, lung cancer and other difficult-to-treat cancers.
ARIAD utilizes computational and structural approaches to design
small-molecule drugs that overcome resistance to existing cancer medicines.
For additional information, visit http://www.ariad.com or follow ARIAD on
ARIAD Pharmaceuticals, Inc.
Kendra Adams, 617-503-7028
Liza Heapes, 617-621-2315
Press spacebar to pause and continue. Press esc to stop.